These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3501538)

  • 1. Preliminary analysis of a randomized comparison of 5-fluorouracil versus 5-fluorouracil and high-dose continuous-infusion folinic acid in disseminated colorectal cancer.
    Doroshow JH; Bertrand M; Newman E; Multhauf P; Leong L; Blayney D; Goldberg D; Margolin K; Carr B; Akman S
    NCI Monogr; 1987; (5):171-4. PubMed ID: 3501538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy.
    Doroshow JH; Multhauf P; Leong L; Margolin K; Litchfield T; Akman S; Carr B; Bertrand M; Goldberg D; Blayney D
    J Clin Oncol; 1990 Mar; 8(3):491-501. PubMed ID: 2407810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical studies of biochemical modulation of 5-fluorouracil by leucovorin in patients with advanced colorectal cancer by the North Central Cancer Treatment Group and Mayo Clinic.
    O'Connell MJ; Klaassen DJ; Everson LK; Cullinan S; Wieand HS
    NCI Monogr; 1987; (5):185-8. PubMed ID: 3501540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin calcium in combination with fluorouracil in patients with advanced colorectal carcinoma.
    Trave F; Rustum YM; Petrelli NJ; Herrera L; Mittelman A; Frank C; Creaven PJ
    J Clin Oncol; 1988 Jul; 6(7):1184-91. PubMed ID: 3260621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Northern California Oncology Group randomized trial of leucovorin plus 5-fluorouracil versus sequential methotrexate, 5-fluorouracil, and leucovorin in patients with advanced colorectal cancer who failed treatment with 5-fluorouracil or 5-fluorodeoxyuridine alone.
    Valone FH; Kohler M; Fisher K; Hannigan J; Flam M; Gandara D; Hendrickson C; Richman E; Yu KP
    NCI Monogr; 1987; (5):175-7. PubMed ID: 2963230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.
    Machover D; Goldschmidt E; Chollet P; Metzger G; Zittoun J; Benavides M; Marquet J; Vandenbulcke JM; Misset JL; Schwarzenberg L
    NCI Monogr; 1987; (5):193-8. PubMed ID: 3501542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous infusion 5-fluorouracil and folinic acid in disseminated colorectal cancer.
    Mortimer JE; Higano C
    Cancer Invest; 1988; 6(2):129-32. PubMed ID: 3259900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: a randomized comparison. A Southwest Oncology Group Study.
    Budd GT; Fleming TR; Bukowski RM; McCracken JD; Rivkin SE; O'Bryan RM; Balcerzak SP; Macdonald JS
    J Clin Oncol; 1987 Feb; 5(2):272-7. PubMed ID: 3543246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic modulation of 5-fluorouracil with high-dose leucovorin and combination chemotherapy of 5-fluorouracil and cisplatin in metastatic colorectal adenocarcinoma.
    Petrelli NJ; Madajewicz S; Herrera L; Rustum YM; Trave F; Creaven P; Mittelman A
    NCI Monogr; 1987; (5):189-92. PubMed ID: 3501541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacokinetic comparison of intravenous versus intra-arterial folinic acid.
    Anderson JH; Kerr DJ; Setanoians A; Cooke TG; McArdle CS
    Br J Cancer; 1992 Jan; 65(1):133-5. PubMed ID: 1733436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral tegafur-uracil plus folinic acid versus intravenous 5-fluorouracil plus folinic acid as adjuvant chemotherapy of colon cancer.
    Kim DJ; Kim TI; Suh JH; Cho YS; Shin SK; Kang JK; Kim NK; Kim WH
    Yonsei Med J; 2003 Aug; 44(4):665-75. PubMed ID: 12950123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. QUASAR Collaborative Group.
    Lancet; 2000 May; 355(9215):1588-96. PubMed ID: 10821362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of 5-fluorouracil (5-FUra) in patients with metastatic colorectal cancer receiving 5-FUra bolus plus continuous infusion with high dose folinic acid (LV5FU2).
    Joulia JM; Pinguet F; Ychou M; Duffour J; Topart D; Grosse PY; Astre C; Bressolle F
    Anticancer Res; 1997; 17(4A):2727-30. PubMed ID: 9252705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of advanced colonic and rectal adenocarcinoma: combination of 5-FU and high-dose folinic acid].
    Rougier P; Droz JP; Ducreux M; Kac J; Spielmann M; Crespon B; Ley G; Zimmermann P; Theodore C; Chavy A
    Bull Cancer; 1983; 70(5):434-6. PubMed ID: 6607759
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of treatment with 5-fluorouracil and folinic acid in patients with carcinoma of the large intestine].
    Nastasi G; Sala L; Romano AM; Nucera D; Anselmetti L; Castoldi O; Crema F; Pasotti D
    Medicina (Firenze); 1988; 8(2):175-8. PubMed ID: 2852292
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase I-II trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer.
    Madajewicz S; Petrelli N; Rustum YM; Campbell J; Herrera L; Mittelman A; Perry A; Creaven PJ
    Cancer Res; 1984 Oct; 44(10):4667-9. PubMed ID: 6331882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas.
    Au JL; Rustum YM; Ledesma EJ; Mittelman A; Creaven PJ
    Cancer Res; 1982 Jul; 42(7):2930-7. PubMed ID: 6211226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly regimen of 5-FU vs 5-FU + intermediate dose folinic acid in the treatment of advanced colorectal cancer.
    Martoni A; Cricca A; Guaraldi M; Covizzi M; Farris A; Pannuti F
    Anticancer Res; 1992; 12(3):607-12. PubMed ID: 1622115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory metastatic breast cancer: salvage therapy with fluorouracil and high-dose continuous infusion leucovorin calcium.
    Doroshow JH; Leong L; Margolin K; Flanagan B; Goldberg D; Bertrand M; Akman S; Carr B; Odujinrin O; Newman E
    J Clin Oncol; 1989 Apr; 7(4):439-44. PubMed ID: 2784492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
    Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Tixi LM; Bolli EA; Rosso R; Mammoliti S; Rollandi GA; Bertoglio S
    Clin Cancer Res; 1995 Sep; 1(9):955-60. PubMed ID: 9816066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.